logo-loader
ASX:1AD

AdAlta Ltd

Receive alerts
Market:
ASX
Price
0.03 AUD
Day Change
4.17%
Market Cap:
$13.15 m
52 weeks high
0.05
52 weeks low
0.02

In brief

AdAlta Ltd (ASX:1AD) is a clinical-stage drug development company using its proprietary i-body technology platform to generate a promising new class of medicines, headquartered in Melbourne, Australia.

The company is using its proprietary i-body technology platform to solve challenging drug targeting problems and generate a promising new class of single domain antibody protein therapeutics.